These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Structure of the O-specific polysaccharides and the protective activity of the lipopolysaccharides in Pseudomonas aeruginosa of 7 immunotypes (after Fisher)]. Stanislavskiĭ ES; Kholodkova EV; Knirel' IuA; Kocharova NA Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):3-7. PubMed ID: 2459868 [TBL] [Abstract][Full Text] [Related]
9. [Immunochemical analysis and protective properties of components of Pseudomonas aeruginosa mucus with different molecular weights]. Zaĭdner IG; Palkina NA; Stanislavskiĭ ES; Landsman NM Zh Mikrobiol Epidemiol Immunobiol; 1981 Apr; (4):92-7. PubMed ID: 6791415 [TBL] [Abstract][Full Text] [Related]
10. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa]. Iushkova NA; Stanislavskiĭ ES; Landsman NM Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the specificity of lipopolysaccharide antigens from seven Fisher's immunotypes of Pseudomonas aeruginosa, using ELISA technique. Trafny EA; Grzybowski J Acta Microbiol Pol; 1988; 37(2):191-204. PubMed ID: 2467530 [TBL] [Abstract][Full Text] [Related]
12. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes]. Kholodkova EV; Fedotova IuM; Stanislavskiĭ ES Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):47-50. PubMed ID: 2446445 [TBL] [Abstract][Full Text] [Related]
13. [Immunologic study of the cellular components of bacillus pyocyaneus. V. Antigenic analysis of slime and its fractions]. Zaĭdner IG; Stanislavskiĭ ES; Kolker II; Grishina IA; Palkina NA Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):41-5. PubMed ID: 91285 [TBL] [Abstract][Full Text] [Related]
14. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines]. Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559 [TBL] [Abstract][Full Text] [Related]
15. [Cell-free pseudomonas vaccine. I. Enzyme properties and virulence of strains of P. aeruginosa; protective activity of their water-soluble antigens]. Stanislavskiĭ ES; Zhvanetskaia MI; Mashilova GM; Gladus MA Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):66-72. PubMed ID: 6778035 [TBL] [Abstract][Full Text] [Related]
16. [Antigenic polysaccharides of bacteria. 21. The structure of O-specific polysaccharide chains and serological specificity of lipopolysaccharides from 7 Pseudomonas aeruginosa immunotypes]. Knirel' IuA; Kocharova NA; Vinogradov EV; Paramonov NA; Dmitriev BA Bioorg Khim; 1987 Jan; 13(1):88-96. PubMed ID: 2436629 [TBL] [Abstract][Full Text] [Related]
17. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa. Gościniak G; Grzybek-Hryncewicz K Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177 [TBL] [Abstract][Full Text] [Related]